GlassScriptPhysician profile
Leroy Rise
NPI 1962697177
$2,888.61
in general payments reported to CMS, 2019-2025
9 companies · $440 in 2025
The $440 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $460 · 2020: $119 · 2021: $37.24 · 2022: $383 · 2024: $1,449 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,403 · Food and Beverage: $486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,403.13 |
| Food and Beverage | $486.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,449.35 | 2024 | Anteralign Spinal System With Titan Nanolock Surface Technology |
| Smith+Nephew, INC. | $510.11 | 2019-2025 | Trigen Intertan |
| Depuy Synthes Sales INC. | $371.19 | 2019-2025 | Tfn-Advance, Lcp |
| Curvafix, INC. | $331.25 | 2022 | |
| Stryker Corporation | $96.67 | 2019 | |
| Ethicon US, LLC | $68.13 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $24.67 | 2025 | |
| Orthofix Medical, INC. | $20.51 | 2021 | |
| Medela LLC | $16.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leroy Rise listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.